Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Oct 9;11(10):1177.
doi: 10.3390/genes11101177.

Clinical Genetics Can Solve the Pitfalls of Genome-Wide Investigations: Lesson from Mismapping a Loss-of-Function Variant in KANSL1

Affiliations
Case Reports

Clinical Genetics Can Solve the Pitfalls of Genome-Wide Investigations: Lesson from Mismapping a Loss-of-Function Variant in KANSL1

Stefania Bigoni et al. Genes (Basel). .

Abstract

Massive parallel sequencing of 70 genes in a girl with a suspicion of chromatinopathy detected the (NM_015443.4:)c.985_986delTT variant in exon 2 of KANSL1, which led to a diagnostic consideration of Koolen De Vries syndrome. The same variant was present in the healthy mother, consistent with either incomplete penetrance or variant mismapping. A network of second opinion was implemented among clinical geneticists first, and a diagnosis of Koolen De Vries syndrome was considered unlikely. By MLPA, a duplication spanning exons 1-3 of KANSL1 was detected in both the mother and the daughter. On cDNA sequencing, biallelic wild type mRNA was observed. We concluded that the variant affects the noncoding duplicated gene region in our family, and we finally classified it as benign. Parallel wide genomic sequencing is increasingly the first genetic investigation in individuals with intellectual disability. The c.985_986delTT variant in KANSL1 was described both in individuals with typical KdVS and in a limited number of healthy subjects. This report highlights the role of clinical genetics to correctly classify variants and to define proper clinical and diagnostic correlations.

Keywords: KANSL1; clinical evaluation; copy number polymorphisms; variant interpretation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the sequencing results at both the genomic and cDNA level of KANSL1. (A) Representation of the genomic region containing KANSL1, obtained with Multi-Region visualization (padding of 30 bases) in the UCSC Genome Browser (GRCh38/hg38 Assembly; genome.ucsc.edu). The blue line with diamond shaped ends represents the 1372 bps segment (spanning exons 2-9) of the KANSL1 cDNA amplified by standard PCR to obtain a unique amplicon. (B) Electropherogram of exon 2 sequencing on genomic DNA, showing the c.985_985delTT variant. (C) Electropherograms of cDNA sequencing on a large amplicon encompassing exons 2 to 9 of KANSL1, showing a wild type exon 2 (C1), along with heterozygous c.1491A>G (C2, exon 4) and heterozygous c.2152T>C (C3, exon 8) variants. These results are consistent with biallelic expression of a functional KANSL1.

References

    1. Koolen D.A., Vissers L.E., Pfundt R., de Leeuw N., Knight S.J., Regan R., Kooy R.F., Reyniers E., Romano C., Fichera M., et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat. Genet. 2006;38:999–1001. doi: 10.1038/ng1853. - DOI - PubMed
    1. Shaw-Smith C., Pittman A.M., Willatt L., Martin H., Rickman L., Gribble S., Curley R., Cumming S., Dunn C., Kalaitzopoulos D., et al. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat. Genet. 2006;38:1032–1037. doi: 10.1038/ng1858. - DOI - PubMed
    1. Sharp A.J., Hansen S., Selzer R.R., Cheng Z., Regan R., Hurst J.A., Stewart H., Price S.M., Blair E., Hennekam R.C., et al. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 2006;38:1038–1042. doi: 10.1038/ng1862. - DOI - PubMed
    1. Koolen D.A., Sharp A.J., Hurst J.A., Firth H.V., Knight S.J., Goldenberg A., Saugier-Veber P., Pfundt R., Vissers L.E., Destrée A., et al. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J. Med. Genet. 2008;45:710–720. doi: 10.1136/jmg.2008.058701. - DOI - PMC - PubMed
    1. Zollino M., Orteschi D., Murdolo M., Lattante S., Battaglia D., Stefanini C., Mercuri E., Chiurazzi P., Neri G., Marangi G. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nat. Genet. 2012;44:636–638. doi: 10.1038/ng.2257. - DOI - PubMed

Publication types

Supplementary concepts

LinkOut - more resources